The Natural Product Center of Excellence seeks to identify novel active compounds for new antibiotics.

Cour Pharmaceutical Development Company, a biopharmaceutical company, has published new data showing that its proprietary nanoparticle therapy could potentially reduce inflammation and promote tissue repair and regeneration in patients who have had a heart attack.

CPhI-InformEx Report will to describe American pharma economy from European and domestic perspectives.

Mentholatum announces a voluntary nationwide recall of Rohto Eye Drops made in Vietnam.

Combined technologies from Agilent Technologies and Picometrics Technologies are designed for large–molecule analysis.

USP opens expanded Shanghai facility to enhance quality standards for medicines and food ingredients.

The Stevens Institute of Technology will open a new biotechnology laboratory in January 2014.

A packaging defect has led to Merck voluntarily recalling all lots of Liptruzet tablets in the United States.

An optical sensor designed by chemists at the Massachusetts Institute of Technology tracks zinc levels to gain insight on prostate cancer.

USP announced the approval of General Notices section 5.60.30 Elemental Impurities in USP Drug Products and Dietary Supplements with an official date of Dec. 1, 2015.

MedImmune has entered into a research collaboration with Immunocore to develop novel cancer therapies.

FDA releases guidance on the qualification of drug development tools.

Research was published describing a natural interferon-alpha for infection control and treatment of drug-resistant H7N9 influenza.

Forest's planned acquisition of Aptalis will enhance its business in gastrointestinal and cystic fibrosis therapies.

Eurofins acquires DDS business of Merck KGaA in order to expand discovery solutions and bioanalytical services.

FDA releases guidance on developing drugs for the treatment of community-acquired bacterial pneumonia.

Ron Piervincenzi to assume leadership of the United States Pharmacopeial Convention on Feb. 1, 2014.

EMA has launched a new version of the EudraGMDP database, which includes the publication of statements of non-compliance with good manufacturing practice.

GE acquires Thermo Fisher's HyClone cell culture media and sera products, gene modulation technologies, and magnetic beads businesses.

A study led by Stanford University explains why men may have weaker responses to vaccines than women.

A monkey-vaccine study provides insight into HIV research.

Roche?s Brain Shuttle technology transfers antibodies through the BBB.

Mac Process will merge with Schenck AccuRate and combine their operations under the name of Schenck Process.

Generics, market dynamics, and global demand are changing drug spending patterns.

Janssen's donation program will improve access to the company's approved HIV medicines for children and adolescents in sub-Saharan Africa.

Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator.

Former US President Jimmy Carter and Pfizer commemorate the 15th anniversary of the International Trachoma Initiative to end blinding trachoma by the year 2020.

Training, calibration, and preventive maintenance help prevent over-and under-weight tablets. The author discusses causes of off-weight tablets and best practices for tableting.